Brief: Natera Says Court Ordered Permanent Injunction Against NeoGenomics' Accused RaDaR Assay, as Case Enters New Phase
23/09/2024 21:15
Sept 23 (Reuters) - Natera Inc NTRA.O :
* NATERA: DISTRICT COURT FOR MIDDLE DISTRICT OF NORTH
CAROLINA
ENTERED PERMANENT INJUNCTION AGAINST NEOGENOMICS' ACCUSED RADAR
ASSAY
* NATERA INC - CONTINUES TO PROSECUTE ITS CLAIM AGAINST A
MODIFIED
VERSION OF RADAR FOR INFRINGEMENT OF NATERA'S '454 PATENT
* NATERA: SEEKS FULL REMEDIES, AFTER PATENT OFFICE DENIED
NEOGENOMICS' PETITION FOR 'INTER PARTES' REVIEW CHALLENGING
VALIDITY OF '454 PATENT
Source text for Eikon: ID:nBw3vLZRCa
Further company coverage: NTRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natera
See all newsBrief: FDA Grants Breakthrough Device Designation For Natera’S Multi-Cancer Early Detection Assay
Brief: Alliance Foundation Trials And Natera Announce Aft-70 Navigate A Global, Randomized, Phase Iii Trial Evaluating Genentech’S Oral Selective Estrogen Receptor Degrader With Signatera Mrd-Guided Cdk4/6 Inhibitor Therapy In Breast Cancer
US RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
Brief: Natera Says Signatera Commercial Launch In Japan Expected In 1H 2027
Brief: Natera To Support New Clinical Trial Assessing Ctdna Dynamics With Latitud In Advanced Skin Cancers